Skip to Content

'
Rajat J. Kudchadker, Ph.D.; DABR

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Service Chief, Genitourinary Service, Department of Radiation Physics - Patient Care, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Residency Program Associate Director, Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor, Graduate School of Biomedical Sciences, The University of Texas Houston Health Science Center, Houston, TX

Education & Training

Degree-Granting Education

1996 University of Missouri, Columbia, MO, PHD, Nuclear Engineering (Medical Physics)
1992 Idaho State University, Pocatello, ID, MS, Physics (Experimental Nuclear Physics)
1988 Fergusson College, Pune, India, MS, Physics (Electronics)
1986 Fergusson College, Pune, India, BS, Physics

Postgraduate Training

4/1999-7/2001 Research Associate, Radiation Physics, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Kenneth R. Hogstrom
7/1996-7/1997 Postdoctoral Research Fellow, Nuclear Physics, Department of Physics, Idaho State University, Pocatello, ID, Dr. Frank Harmon

Board Certifications

5/2005 American Board of Radiology

Experience/Service

Academic Appointments

Assistant Professor, Department of Radiation Physics - Patient Care, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 9/2003-9/2009
Visiting Assistant Professor, Department of Physics and College of Engineering, Idaho State University, Pocatello, ID, 7/1997-4/1999

Other Appointments/Responsibilities

Chair, Work Group on Coordination of Medical Physics residency Programs, American Association of Physicists in Medicine, College Park, MD, 1/2013-present
Member, Working Group on Coordination of Medical Physics Residency Programs, American Association of Physicists in Medicine, College Partk, MD, 10/2012-present
Member, On-Line Continuing Education Subcommittee, American Association of Physicists in Medicine, College Park, MD, 9/2009-present
Faculty Member, Graduate School of Biomedical Sciences, The University of Texas, Houston, TX, 8/2004-present

Institutional Committee Activities

Member, Department of Radiation Physics Recruitment Committee, 2014-present
Committee Member, Diversity Council, 2013-present
Committee Chair, Department of Radiation Physics Faculty Mentoring Program, 2013-present
Committee Member, Faculty Senate Promotion and Tenure Issues Committee, 2013-present
Co-Chair, Diversity Council - Communication and Involvement Subcommittee, 2013-present
Senator, Faculty Senate, 2012-present
Committee Member, FPPE Review Oversight Committee, 2012-present
Committee Member, Credentials Committee of the Medical Staff, 2011-present
Member, Department of Radiation Physics Steering Committee, 2011-present

Honors and Awards

2012 Radiation oncology residents LDR prostate brachytherapy training program, American Brachytherapy Society
2007 AAMD Best Manuscript Award, American Association of Medical Dosimetrists
2006 Clinical Physics Service Leadership Award, The University of Texas M.D. Anderson Cancer Center
1997 HPS Best Poster Award, Idaho Chapter of Health Physics Society
1996 Best Young Investigator Award, Health Physics Society
1996 Research and Creative Activities Forum Best Paper Award, University of Missouri
1996 Travel Award, Health Physics Society
1995 Reactor Summer School Scholarship, Health Physics Society
1995 Service to Nuclear Engineering Award, American Nuclear Society
1995 Travel Award, Health Physics Society
1993 Travel Award, Health Physics Society

Professional Memberships

American Association of Physicist in Medicine (AAPM) Southwest Regional, TX
President Elect, 1/2014-present
Secretary, 1/2012-12/2013
American Association of Physicist in Medicine (AAPM) Southwest Regional
Mock Oral Examiner, 2010-present
American Association of Physicists in Medicine, College Park, MD
Annual Meeting Abstract Reviewer, 1/2013-present
American Association of Physicists in Medicine, College Park, MD
Working Group on Coordination of Medical Physics Residency Programs, 10/2012-present
American Association of Physicists in Medicine, College Park, MD
Member, On-Line Continuing Education Subcommittee, 1/2010-12/2013
American Association of Physicists in Medicine (AAPM), College Park, MD
Member, 1996-present
American Brachytherapy Society, Reston, VA
Member, 10/2010-present
American Society for Radiation Oncology, Fairfax, VA
Member, 1/2012-present
Health Physics Society (HPS), McLean, VA
Member, 1992-present
International Society of Hybrid Microelectronics (ISHM), Bombay, India
Life Member, 1988-present
Sigma Xi, Research Triangle Park, NC
Member, 1997-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Thaker NG, Kudchadker RJ, Albert JM, Pugh TJ, Mahmood U, Bruno TL, Kuban DA, Frank SJ. Establishing high quality prostate brachytherapy using a phantom simulator training program. Int J Radiat Oncol Biol Phys. In Press.
2. Yock AD, Rao A, Dong L, Beadle BM, Kudchadker RJ, Court LE. Forecasting longitudinal changes in oropharyngeal tumor morphology throughout the course of head and neck radiation therapy. Med Phys. In Press.
3. Wang J, Kudchadker RJ, Choi S, Pettaway CA, Choi H, Hobbs B, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Practical Radiation Oncology. In Press.
4. Lim TY, Stafford RJ, Kudchadker RJ, Sankaranarayanapillai M, Ibbott G, Rao A, Martirosyan KS, Frank SJ. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Phys Med Biol 59(10):2505-2516, 5/21/2014. e-Pub 4/28/2014. PMCID: PMC4090919.
5. Yock AD, Rao A, Dong L, Beadle BM, Garden AS, Kudchadker RJ, Court LE. Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pre-treatment computed tomography data using general linear models. Med Phys 41(5):051705, 5/2014. PMID: 24784371.
6. Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. Int J Radiat Oncol Biol Phys 88(5):1074-84, 4/1/2014. PMID: 24661661.
7. Wootton L, Kudchadker R, Lee A, Beddar S. Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer. Phys Med Biol 59(3):647-60, 2/7/2014. e-Pub 1/17/2014. PMCID: PMC3965908.
8. Du W, Cho SH, Zhang X, Hoffman KE, Kudchadker RJ. Quantification of beam complexity in intensity-modulated radiation therapy treatment plans. Med Phys 41(2):021716, 2/2014. PMID: 24506607.
9. Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U, Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy 13(1):68-74, Jan-Feb, 1/2014. e-Pub 5/11/2013. PMID: 23669149.
10. Gossman MS, Hancock SS, Kudchadker RJ, Lundahl PR, Cao M, Melhus CS. Brachytherapy dose-volume histogram commissioning with multiple planning systems. J Appl Clin Med Phys 15(2):110-120, 2014. e-Pub 3/6/2014. PMID: 24710449.
11. Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis 16(4):1-6, 12/2013. e-Pub 8/2013. PMID: 23939133.
12. Melancon AD, Kudchadker RJ, Amos R, Johnson JL, Zhang Y, Yu ZH, Zhang L, Dong L. Patient-specific and generic immobilization devices for prostate radiotherapy. Int J of Med Phys Clin Engr and Radiat Onc 2(4):125-132, http://www.scirp.org/journal/ijmpcero, 11/2013.
13. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, van Vulpen M, Frank SJ. Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer. Brachytherapy 12(5):401-7, Sep-Oct, 9/2013. e-Pub 2/2013. PMID: 23380383.
14. Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, Du W, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 86(5):835-41, 8/2013. e-Pub 5/2013. PMID: 23726001.
15. Cheung JP, Park PC, Court LE, Ronald Zhu X, Kudchadker RJ, Frank SJ, Dong L. A novel dose-based positioning method for CT image-guided proton therapy. Med Phys 40(5):051714, 5/2013. PMCID: PMC3651206.
16. Register SP, Kudchadker RJ, Levy LB, Swanson DA, Pugh TJ, Bruno TL, Frank SJ. An MRI-based dose-response analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a Phase II Prospective Trial. Brachytherapy 12(3):210-6, May-Jun, 5/2013. e-Pub 3/2013. PMID: 23466360.
17. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy. Brachytherapy 12(3):204-9, May-Jun, 5/2013. e-Pub 6/2012. PMID: 22673704.
18. Albert JM, Swanson DA, Pugh TJ, Zhang M, Bruno TL, Kudchadker RJ, Frank SJ. Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy 12(1):30-7, Jan-Feb, 1/2013. e-Pub 6/2012. PMID: 22727474.
19. McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose escalated radiation therapy era. Int J Radiat Oncol Biol Phys 85(1):e39-46, 1/2013. e-Pub 10/2012. PMID: 23102837.
20. Melancon AD, Lee AK, Kudchadker RJ, Zhang L, Tucker SL, Kuban D, Dong L. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiotherapy for prostate cancer. Pract Rad Oncol 3(4):329-336, http://www.practicalradonc.org/, 2013.
21. Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ. Dosimetric effects of weight loss or gain during volumetric-modulated arc therapy and intensity-modulated radiation therapy for prostate cancer. Med Dosim 38(3):251-4, 2013. e-Pub 3/2013. PMID: 23540491.
22. Klein D, Briere TM, Kudchadker R, Archambault L, Beaulieu L, Lee A, Beddar S. In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiat Meas 47(10):921-929, 10/2012. e-Pub 8/2012. PMCID: PMC3501761.
23. Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys 83(4):1169-78, 7/2012. PMID: 22704703.
24. Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of rectal complications following brachytherapy. Pract Rad Oncol 2(3):7-13, http://www.practicalradonc.org/, 7/2012. e-Pub 7/2012.
25. Du W, Gao S, Wang X, Kudchadker RJ. Quantifying the gantry sag on linear accelerators and introducing an MLC-based compensation strategy. Med Phys 39(4):2156-2163, 4/2012. PMCID: PMC3326073.
26. Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ. Sexual Function and the use of Medical Devices or Drugs to Optimize Potency after Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 82(5):765-771, 4/2012. e-Pub 1/2012. PMID: 22300559.
27. Kim MM, Kudchadker RJ, Kanke JE, Zhang S, Perkins GH. Bolus electron conformal therapy for the treatment of recurrent inflammatory breast cancer: A case report. Med Dosim 37(2):208-13, 2012. e-Pub 10/2011. PMID: 21978532.
28. Wootton LS, Kudchadker RJ, Beddar AS, Lee AK. Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy. J Appl Clin Med Phys 13(5):3945, 2012. e-Pub 9/2012. PMID: 22955660.
29. Kudchadker RJ, Pugh TJ, Swanson DA, Bruno TL, Bolukbasi Y, Frank SJ. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy. Med Dosim 37(4):387-390, 2012. e-Pub 5/2012. PMID: 22560295.
30. Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ. Long-term tumor control after brachytherapy for base of prostate cancer. J Contemp Brachytherapy 3(4):183-187, 12/2011. e-Pub 12/2011. PMCID: PMC3551361.
31. Vassiliev ON, Kudchadker RJ, Swanson DA, Bruno TL, van Vulpen M, Frank SJ. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy 10(5):401-408, Sep-Oct, 9/2011. e-Pub 2/2011. PMID: 21306959.
32. Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen Q, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med 28(3), August 27 2011. e-Pub 8/2011. PMID: 21875820.
33. Huang JY, Newhauser WD, Zhu XR, Lee AK, Kudchadker RJ. Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate. Phys Med Biol 56(16):5287-302, 8/2011. e-Pub 7/2011. PMCID: PMC3171138.
34. Shirvani SM, Kudchadker RJ, Bruno TL, Likhacheva A, Swanson DA, Frank SJ. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125. Brachytherapy 10(4):269-74, Jul-Aug, 7/2011. e-Pub 2/2011. PMID: 21296031.
35. Kry SF, Johnson JL, White RA, Howell RM, Kudchadker RJ, Gillin MT. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys 38(1):34-39, 1/2011. e-Pub 1/2011. PMID: 21361172.
36. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim 36(2):200-5, 2011. e-Pub 5/2010. PMID: 20537886.
37. Li H, Lee AK, Johnson JL, Zhu RX, Kudchadker RJ. Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches. J Appl Clin Med Phys 12(3):23-31, 2011. e-Pub 3/2011. PMID: 21844859.
38. Sha RL, Reddy PY, Rao R, Muralidhar KR, Kudchadker RJ. Evaluation of rectal dose during high-dose rate intracavitary brachytherapy for cervical carcinoma. Med Dosim 36(4):377-82, 2011. e-Pub 12/2010. PMID: 21144733.
39. Cheung J, Kudchadker RJ, Zhu XR, Lee AK, Newhauser WD. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer. Phys Med Biol 55(23):7135-7147, 12/2010. e-Pub 11/2010. PMID: 21076190.
40. Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity modulated radiation therapy. Am J Clin Oncol 33(2):173-175, 4/2010. PMID: 20010077.
41. Brooks C, Cheung RM, Kudchadker RJ. Intensity-modulated radiation therapy with noncoplanar beams for treatment of prostate cancer in patients with bilateral hip prosthesis-a case study. Med Dosim 35(2):87-91, 2010. e-Pub 4/2009. PMID: 19931019.
42. Zullo JR, Kudchadker RJ, Zhu XR, Sahoo N, Gillin MT. LiF TLD-100 as a dosimeter in high energy proton beam therapy - Can it yield accurate results? Med Dosim 35(1):63-66, 2010. e-Pub 4/2009. PMID: 19931017.
43. Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ. Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience. Urology 74(3):601-5, 9/2009. e-Pub 7/2009. PMID: 19589580.
44. Kudchadker RJ, Lee AK, Yu ZH, Johnson JL, Zhang L, Zhang Y, Amos RA, Nakanishi H, Ochiai A, Dong L. Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int J Radiat Oncol Biol Phys 74(4). e-Pub 5/2009. PMID: 19427750.
45. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ.. Late Rectal Complications after prostate brachytherapy for localized prostate cancer: Incidence and Management. Cancer 115(9):1827-1839, 5/2009. e-Pub 2/2009. PMID: 19248043.
46. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, van Vulpen M, Swanson DA.. Prostogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on the M.D. Anderson Cancer Center experience with Iodine-125 brachytherapy. J Urol 181(4). e-Pub 2/2009. PMID: 19233434.
47. Weinberg R, Antolak JA, Starkschall G, Kudchadker RJ, White RA and Hogstrom KR. Influence of source parameters on large-field electron beam profiles calculated using Monte Carlo methods. Phys Med Biol 54(1):105-116, 1/2009. e-Pub 12/2008. PMID: 19075360.
48. Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK. Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans. Int J Radiat Oncol Biol Phys 75(1). e-Pub 12/2008. PMID: 19058919.
49. Nelson C, Balter P, Morice RC, Choi B, Kudchadker RJ, Bucci K, Chang JY, Dong L, Tucker S, Vedam S, Briere T, Starkschall G. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. J Appl Clin Med Phys 9(4):110-122, 10/2008. e-Pub 2008. PMID: 19020478.
50. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era? Int J Radiat Oncol Biol Phys 72(2):623-627, 9/2008. PMID: 18410998.
51. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-20, 7/2008. e-Pub 1/2008. PMID: 18207664.
52. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A novel MRI marker for prostate brachytherapy. Int J Radiat Oncol Biol Phys 71(1):5-8, 5/2008. PMID: 18406882.
53. O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71(1):274-280, 5/2008. PMID: 18406891.
54. Zullo JR, Kudchadker R, Wu R, Lee A, Prado K. Implication of CT table sag on geometrical accuracy during virtual simulation. Med Dosim 32(4):233-236, 11/2007. PMID: 17980822.
55. Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? Radiother Oncol 85(2):251-259, 9/2007. PMID: 17892900.
56. de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys 68(5):1529-36, 6/2007. PMID: 17544595.
57. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67(4):1059-1065, 1/2007. PMCID: PMC2081969.
58. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 66(3):883-91, 11/2006. PMID: 17011461.
59. Kudchadker RJ, Chang EL, Bryan F, Maor MH, Famiglietti R. An evaluation of radiation exposure from portal films taken during definitive course of pediatric radiotherapy. Int J Radiat Oncol Biol Phys 59(4):1229-35, 7/2004. PMID: 15234060.
60. Zullo JR, Bloch C, Chi PC, Kudchadker R. Linearity and uniformity response as an indicator of performance for Agfa ADC-MD10 computed radiography plates. Med Dosim 29(2):118-21, 2004. PMID: 15191759.
61. Kirsner SM, Kudchadker RJ, Prado KL, Ha CS, Wilder RB, Cox JD. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation. Int J Radiat Oncol Biol Phys 55(4):1135-42, 3/2003. PMID: 12605993.
62. Prado KL, Kirsner SM, Kudchadker RJ, Steadham RE, Lane RG. Enhanced dynamic wedge factors at off-axis points in asymmetric fields. J Appl Clin Med Phys 4(1):75-84, 2003. PMID: 12540821.
63. Kudchadker RJ, Antolak JA, Morrison WH, Wong PF, Hogstrom KR. Utilization of custom electron bolus in head and neck radiotherapy. J Appl Clin Med Phys 4(4):321-33, 2003. PMID: 14604422.
64. Kudchadker RJ, Hogstrom KR, Garden AS, McNeese MD, Boyd RA, Antolak JA. Electron conformal radiotherapy using bolus and intensity modulation. Int J Radiat Oncol Biol Phys 53(4):1023-37, 7/2002. PMID: 12095572.
65. Lee CL, Zhou XL, Kudchadker RJ, Harmon F, Harker YD. A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy. Med Phys 27(1):192-202, 2000. PMID: 10659757.
66. Kudchadker RJ, Hogstrom KR, Boyd RA. Multileaf collimation for electron intensity modulation. IEEE Engineering in Medicine and Biology 1:210-213, 2000.
67. Lee C, Zhou X, Harmon F, Bartholomay R, Harker Y, Kudchadker RJ. Thermal neutron flux mapping in a head phantom. Nuclear Instruments and Methods 422(1):106-110, 2/1999.

Abstracts

1. Du W, Cho S, Zhang X, Hoffman K, Kudchadker RJ. Decoding the beam complexity in intensity-modulated radiation therapy plans. Med Phys 41(6):305, 6/2014.
2. Yock A, Rao A, Dong L, Beadle B, Garden A, Kudchadker RJ, Court L. Forecasting longitudinal changes in oropharyngeal tumor morphology throughout the course of head and neck radiation therapy. Med Phys 41(6):414, 6/2014.
3. Wootton L, Kudchadker RJ, Lee A, Beddar S. Results from a 5 patient in vivo rectal wall dosimetry study using plastic scintillation detectors. Med Phys 41(6):96, 6/2014.
4. Lim T, Wang J, Kudchadker R, Stafford J, Bathala T, Pugh T, Ibbott G, Frank S. Sirius MRI markers for prostate post-implant assessment: MR protocol development. Med Phys 41(6):99, 6/2014.
5. Cheung JP, Dong, L, Park P, Zhu XR, Kudchadker RJ, Frank SJ, Court LE. Successes and limitations of online range adaptive spot scanning proton therapy for NSCLC. Med Phys 41(6):552, 6/2014.
6. Thaker NG, Kudchadker RJ, Swanson DA, Albert JA, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Frank SJ. A phantom based simulator approach to improving the quality of prostate brachytherapy training. Proceedings of the American Radium Society 96th annual meeting, 2014.
7. Bishop AJ, Levy L, Braccioforte MH, Moran BJ, Crook JM, Van Vulpen M, Grimm P, Swanson DA, Mahmood U, Pugh TJ, Kudchadker RJ, Frank SJ. Evaluating the face of failure: a model to predict prostate cancer recurrences using PSA trends following brachytherapy implant. Proceedings of the American Radium Society 96th annual meeting, 2014.
8. Kudchadker RJ, Wootton LS, Lee AK, Beddar AS. Localization methodology for water-equivalent plastic scintillation detectors using surrogate fiducials in CT. 2nd ESTRO Forum, 4/2013.
9. Beddar S, Wootton LS, Kudchadker RJ, Lee AK. Preliminary results of an online patient in-vivo dosimetry protocol to monitor anterior rectal wall dose in real time. 2nd ESTRO Forum, 4/2013.
10. Du W, Casey K, Kudchadker RJ. Automated analysis of leaf position accuracy for multi-leaf collimator quality assurance. Med Phys 40(6):234, 2013.
11. Kudchadker RJ, Lim T, Du W, Mahmood U, Pugh TJ, Frank SJ. Cesium-131 stranded seed nomogram for a prospective phase II intermediate-risk low dose rate prostate brachytherapy clinical trial. Brachytherapy 12:S68, 2013.
12. Lim TY, Frank SJ, Pugh TJ, Bruno TL, Kudchadker RJ. Comparison of two treatment planning systems Variseed and MIM for low dose rate prostate brachytherapy. Brachytherapy 12:S68, 2013.
13. Cheung J, Court L, Park P, Zhu XR, Frank S, Kudchadker RJ, Dong L. Evaluation of various spot MU correction methods for range adaptive scanning-beam proton planning. Med Phys 40(6):359, 2013.
14. Yock A, Rao A, Dong L, Beadle B, Zhang L, Yang J, Kudchadker R, Court L. Hierarchical clustering and classification improve the prediction of GTV response throughput the course of head and neck IMRT. Med Phys 40(6):200, 2013.
15. Lim TY, Stafford RJ, Sankaranarayanapillai M, Martirosyan K, Kudchadker RJ, Frank SJ. MRI characteristics of cobalt dichloride N-acetyl cysteine (C4) as a contrast agent marker for prostate brachytherapy. Med Phys 40(6):461, 2013.
16. Cheung J, Dong L, Park P, Zhu XR, Kudchadker RJ, Frank SJ, Palmer Matthew; Liu W, Court L. Prediction of sensitivity of IMPT plans to anatomical change due to plan complexity. Med Phys 40(6):363, 2013.
17. Pugh TJ, Kudchadker RJ, Mahmood U, Bruno TL, Frank SJ. Prostate brachytherapy treatment planning using T2 weighted cube 3D magnetic resonance imaging (MRI) without an endorectal coil. Brachytherapy 12:S72, 2013.
18. Yu Z, Yang J, Dong L, Zhang Y, Court L, Mourtada F, Tucker S, Klopp A, Eifel P, Kudchadker RJ. Voxel-by-voxel validation of deformable image registration between external beam and intracavitary brachytherapy images using artificial CT images created from patient populations. Med Phys 40(6):90, 2013.
19. Anand A, Kerns J, Du W, Kudchadker RJ. A novel method using Agfa-Kodak computer radiography system for routine quality assurance tests on linear accelerators. Med Phys 39(6):3718, 6/2012.
20. Yu Z, Klopp A, Kudchadker R, Mourtada F, Eifel P, Park P, Dong L. A universal margin reconstruction method for estimating anatomy induced proton range uncertainties. Med Phys 39(6):3904, 6/2012.
21. Du W, Gao S, Wang X, Kudchadker RJ. Evaluating gantry sag on linear accelerators and introducing an MLC based compensation strategy. Med Phys 39(6):3722, 6/2012.
22. Cheung J, Park P, Zhu X, Frank SJ, Court L, Kudchadker R, Dong L. Feasibility of online range adaptive spot scanning proton therapy. Med Phys 39(6):3998, 6/2012.
23. Anand A, Du W, Chung H, Frank SJ, Pugh TJ, Kudchadker RJ. M.D. Anderson prostate seed implant dose calculator. Med Phys 39(6):3713, 6/2012.
24. Yang M, Du W, Frank SJ, Pugh TJ, Bruno TL, Kudchadker RJ. Radiation exposure estimation for 131Cs prostate implant patient release determination. Med Phys 39(6):3763, 6/2012.
25. Frank SJ, Madden T, Swanson DA, Martirosyan K, Uthamanthil R, Stafford J, Gagea M, Pugh TJ, Kudchadker RJ, Johansen MJ. C4 markers for MRI-based prostate brachytherapy. Radiother Oncol 103(Suppl 2):S91, 5/2012.
26. Klein DM, Wootton LS, Kudchadker RJ, Lee AK, Beddar AS. In-phantom dose verification of four-field box and IMRT treatment delivery using plastic scintillation detectors. Radiother Oncol 103(Suppl 2):S126-S127, 5/2012.
27. Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Munsell MF, Frank SJ. Prospective evaluation of pharmacologic penile rehabilitation following prostate brachytherapy. Radiother Oncol 103(Suppl 2):S91-S92, 5/2012.
28. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, Frank SJ. Improving Prostate Brachytherapy Quality Assurance with MRI-based Sector Analysis in a Phase II Prospective Trial. Int J Radiat Oncol Biol Phys 81(2):S209, 10/2011.
29. Christensen EN, Pugh TJ, Munsell MF, Swanson DA, Kudchadker RJ, Bruno TL, Brown AP, Frank SJ. Sector Analysis of Prostate Brachytherapy Shows That Low Doses can Achieve an Undetectable PSA. Int J Radiat Oncol Biol Phys 81(2):S422, 10/2011.
30. Wootton LS, Zhu XR, Kudchadker RJ, Sharma RJ, Choi B, Taylor MB, Dong L, Johnson JL, Nguyen QN, Choi S, Lee AK. Comparison of fiducial and bony-anatomy based alignment for prostate localization in proton therapy. Med Phys 38(6):3609, 7/2011.
31. Huang JY, Newhauser WD, Zhu XR, Lee AK, Kudchadker RJ. Investigation of dose perturbations and radiographic visibility of potential fiducials for proton radiation therapy of the prostate. Med Phys 38(6):3778, 7/2011.
32. Kudchadker RJ, Pugh TJ, Bruno TL, Du W, Swanson DA, Frank SJ. Optimizing quality assurance in a prospective phase II clinical trial for intermediate risk prostate cancer with brachytherapy as monotherapy using a Palladium-103 stranded seed nomogram. Med Phys 38(6):3625, 7/2011.
33. Frank SJ, Munsell MF, Pugh TJ, Kudchadker RJ, Bruno TL, Swanson DA. Long-term outcomes, quality of life, and patient-reported satisfaction following prostate brachytherapy: The MD Anderson cancer center experience. Brachytherapy 10((1,Suppl)):S16-S17, 5/2011.
34. Pugh TJ, Frank SJ, Kudchadker RJ, Swanson DA, Davis JW. Prostate MRI in men with intermediate risk prostate cancer: Implications for prostate brachytherapy monotherapy. Brachytherapy 10((1,Suppl)):S30, 5/2011.
35. Cheung JP, Park PC, Zhu XR, Court LE, Frank SJ, Kudchadker RJ, Dong L. Comparison of dosimetric benefit of online dose-guided alignment versus anatomy guided alignment for proton therapy. Med Phys 38(6):3854, 2011.
36. Kudchadker RJ, Du W, Bruno TL, Pugh TJ, Frank SJ. Treatment planning dosimetry comparison between model 9011 I-125 thinseed and Model 6711 I-125 seeds for prostate brachytherapy. Med Phys 38(6):3625, 2011.
37. Choi S, Johnson JL, Kudchadker RJ, Dong L, Lee AK. Analysis of Fiducial Migration for Prostate Cancer Patients undergoing Image-Guided Radiation Therapy (IGRT). Int J Radiat Oncol Biol Phys 78((3,Suppl)):S676, 11/2010.
38. Morikawa LK, Kudchadker R, Kanke J, Oyervides M, Frank S, Lee AK, Hoffman K, Choi S, Nguyen Q, Kuban DA. Endorectal Balloon in Post-Operative Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 78((3,Suppl)):S395, 11/2010.
39. Albert JM, Zhang M, Bruno TL, Kudchadker RJ, Swanson DA, Frank SJ. MRI-Based Treatment Planning for Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78((3,Suppl)):S372-S373, 11/2010.
40. Zhang M, Munsell MF, Swanson DA, Kudchadker RJ, Albert JM, Urbauer DL, Kuban DA, Bruno TL, Frank SJ. Patients Can Expect Long-term Satisfaction After Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78((3,Suppl)):S367, 11/2010.
41. Kudchadker RJ, Nguyen Q, Vu K, Wootton L, Vassiliev O, Choi S, Frank S, Johnson J, Kuban D, Lee AK. Dosimetric Evaluation of the Use of Air or Water Filled Endorectal Balloons for Prostate IMRT Patients. Med Phys 37(6):3225, 6/2010.
42. Kry S, Johnson J, White R, Howell R, Kudchadker R, Gillin M. Neutron-Induced Electronic Failures Around a High-Energy Linear Accelerator. Med Phys 37(6):3162, 6/2010.
43. Melancon A, Lee A, Kudchadker R, Titt U, Beddar S, Zhu X, Dong L. Range Adaptive Proton Therapy for Prostate Cancer. Med Phys 37(6):3332, 6/2010.
44. Kudchadker RJ, Swanson D, Bruno T, Frank SJ. Real-Time Intraoperative Planning Is Not Required to Achieve Consistent High Quality Implants for Prostate Brachytherapy. Med Phys 37(6):3204, 6/2010.
45. Frank SJ, Register SP, Levy L, Kudchadker RJ, Bruno TL, Swanson DA. An MRI dose response analysis for urinary morbidity following prostate brachytherapy monotherapy in a phase II prospective trial. Brachytherapy 9(2):S42, 5/2010.
46. Morikawa L, Kudchadker RJ, Kanke J, Choi S, Nguyen Q, McGuire S, Hoffman K, Frank S, Lee A, Kuban D. Endorectal Balloon in Post-operative Prostate Cancer Patients: Who benefits from it?. Jornada Paulista de Radiologia, 5/2010.
47. Shirvani SM, Kudchadker RJ, Bruno TL, Swanson DA, Frank SJ. Letting the catheter out of the bag:The effect of urinary catheterization on post-implant dosimetry after prostate brachytherapy with Palladium-103. Proceedings of the American Radium Society 92nd Annual Meeting:49, 5/2010.
48. Sharp HJ, Swanson DA, Zhang M, Phan J, Bruno TL, Kudchadker RJ, Kuban DA, Lee AK, Choi S, Nguyen Q, Frank SJ. Prostate brachytherapy preceded by screening colonoscopy diagnosis colorectal cancers in asymptomatic patients. Proceedings of the American Radium Society 92nd Annual Meeting:46, 5/2010.
49. Nguyen QN, Kudchadker RJ, Vu K, Wootton LS, Levy L, Choi S, Johnson JL, Frank SJ, Kuban DA, Lee AK. Rectal sparing with utilization of an endo-rectal balloon for prostate patients treated with an IMRT technique. Proceedings of the American Radium Society 92nd Annual Meeting:53, 5/2010.
50. Vassiliev ON, Kudchadker RJ, Kuban DA, Lee AK. Dosimetric impact of gold fiducial markers in patients undergoing external beam radiation therapy. Med Phys 36(6):2491-2492, 6/2009.
51. Kudchadker RJ, Li H, Johnson JL, Lee AK. Imaging study to determine appropriate implanted fiducial markers for proton or photon image guided radiation therapy. Med Phys 36(6):2485, 6/2009.
52. Melancon AD, Archambault L, Lee AK, Kudchadker RJ, Zhang L, Beddar S, Titt U, Dong L. In vivo detection of the anterior rectal wall using a scintillating fluid-filled rectal balloon for prostate cancer radiotherapy. Med Phys 36(6):2431, 6/2009.
53. Li H, Lee AK, Zhu XR, Kudchadker RJ. The effect of treatment couch attenuation on radiation dose for megavoltage photon beams. Med Phys 36(6):2580, 6/2009.
54. Frank SJ, Tailor R, Martirosyan K, Stafford J, Swanson D, Sing D, Choi J, Elliot A, Mourtada F, Kudchadker R, Ibbott G. C4 MRI ECAMS have no effect on 125I seed anisotropy and are visible after radiation exposure. Brachytherapy 8(2):172, 2009.
55. Whaley JT, Levy LB, Swanson DA, Kudchadker RJ, Bruno TL, Frank SJ. Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy. Brachytherapy 8(2):173, 2009.
56. Johnson JL, Kudchadker RJ, Dong L, Lee AK. Comparison of prostate localization methods: CT-prostate, CT-bone, intraprostatic fiducials and ultrasound guidance. Int J Radiat Oncol Biol Phys 72(1):S572, 9/2008.
57. Weinberg R, Antolak JA, Hogstrom KR, Starkschall G, Kudchadker RJ, White RA, Oh JL. Electron intensity modulation with multileaf collimation for mixed-beam partial breast irradiation. Int J Radiat Oncol Biol Phys 72(1):S527, 9/2008.
58. Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK. Evaluation of dose changes to target and critical structures from rotational setup errors (RSE) in prostate cancer patients treated with proton therapy. Int J Radiat Oncol Biol Phys 72(1):S321, 9/2008.
59. Frank SJ, Fisher C, Levy L, Kudchadker RJ, Kuban DA, Lee AK, Cheung M, Choi S, Bruno T, Swanson DA. Pre-implant urinary symptoms predict for worse urinary outcomes. Int J Radiat Oncol Biol Phys 72(1):S502, 9/2008.
60. Vassiliev O, Kudchadker RJ, Swanson DA, Kuban DA, Bruno T, Frank SJ. Systematic evaluation of periurethral stranded seed migration and its dosimetric consequences in prostate brachytherapy. Int J Radiat Oncol Biol Phys 72(1):S582, 9/2008.
61. Lee AK, Kudchadker RJ, Choi B, Choi S, Bluett J, Zhu R, Dong L. The effectiveness of rectal balloon and orthogonal imaging for proton therapy of prostate cancer. Int J Radiat Oncol Biol Phys 72(1):S553, 9/2008.
62. Kudchadker RJ, Schinkel CG, Choi S, Lee AK. Use of a hand-held bladder scanner to achieve a reproducible daily bladder volume for proton irradiation of the prostate. Int J Radiat Oncol Biol Phys 72(1):S575, 9/2008.
63. Schinkel C, Kudchadker RJ, Choi S, Lee AK. Clinical utility of a portable ultrasound bladder scanner in prostate external-beam radiation therapy. Med Phys 35(6):2690, 6/2008.
64. Weinberg R, Antolak J, Starkschall G, Kudchadker R, Hogstrom K. Electron intensity modulation for mixed-beam radiation therapy with an X-Ray multi-leaf collimator. Med Phys 35(6):2985, 6/2008.
65. Melancon A, Lee AK, Kudchadker RJ, Dong L. Improving rectal sparing with a single anterior proton beam: a planning study. Med Phys 35(6):2833, 6/2008.
66. Lee AK, Levy L, Dong L, Cheung R, Choi S, Frank S, Johnson J, Kudchadker R, Kuban D. IMRT for prostate cancer: The M.D. Anderson experience. Proceedings of the 90th American Radium Society Meeting:13, 5/2008.
67. Phan J, Swanson DA, Kuban DA, Lee AK, Cheung R, Choi S, Kudchadker R, Bruno T, Levy LB, and Frank SJ. Long-term rectal complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings of the 90th American Radium Society Meeting.:40, 5/2008.
68. Anderson JF, Swanson DA, Kuban DA, Lee AK, Cheung RM, Choi S, Kudchadker R, Bruno T, Levy LB, Frank SJ. Long-term urinary complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings of the 90th American Radium Society Meeting.:39, 5/2008.
69. Frank SJ, Stafford RJ, Bankson JA, Swanson DA, Kudchadker RJ, Martirosyan KS. A novel MRI-based approach to prostate brachytherapy. Brachytherapy 7(2):101-102, 4/2008.
70. Sejpal SV, Amos RA, Bluett J, Levy LB, Kudchadker RJ, Choi S and Lee AK. Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans. Proceedings of the American Association of Clinical Oncology Genitourinary Cancer Symposium. 2008.
71. Frank SJ, Kuban DA, Lee AK, Levy LB, Kudchadker R, Bruno T, Swanson DA. Prostate Brachytherapy – The M.D. Anderson Cancer Center Experience. The Journal of Urology 179(4):396-397, 2008. e-Pub 5/2008.
72. Sahoo N, Zhu XR, Zhu M, Amos R, Kudchadker RJ, Johnson J, Arjomandy B, Lii M, Wu R, Gillin MT. Analysis of the accuracy of a monitor unit calculation procedure for passively scattered proton therapy beams. Int J Radiat Oncol Biol Phys 69(3):S689-S690, 11/2007.
73. Lee AK, Kudchadker RJ, Amos RA, Johnson JL, Choi SL, Kuban DA, Cox JD, Mohan R, Gillin M, Dong L. Proton therapy vs. IMRT for prostate cancer: A dosimetric comparison. Int J Radiat Oncol Biol Phys 69(3):S342, 11/2007.
74. Yu ZH, Kudchadker RJ, Zhang L, Johnson J, Zhang Y, Amos R, Nakanishi H, Ochiai A, Dong L, Lee AK. The effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int J Radiat Oncol Biol Phys 69(3):S629-S630, 11/2007.
75. Balter P, Lindsay P, Kudchadker R, Nelson C, T Briere, Vedam S, Komaki R and Mohan R. A comparison of a point based tool with an image overlay tool for fiducial based setup. Med Phys 34(6):2372, 6/2007.
76. O'Daniel J, Kudchadker R, Zullo J and Gillin M. Clinical beam tuning of low-energy electron beams: matching Varian and Siemens linear accelerators. Med Phys 34(6):2424, 6/2007.
77. Lindsday P, Choi B, Bucci M, Zhang L, Dong L, Kudchadker R, Zhu X and Balter P. Comparison of image registration tools used for daily KV imaging-based patient setup. Med Phys 34(6):2372, 6/2007.
78. Zullo J, Kudchadker R, Lindsay P, Zhu X and Gillin M. Dose measurement accuracy of TLD-100 in the bragg peak region of a therapeutic proton beam. Med Phys 34(6):2439, 6/2007.
79. Melancon A, Dong L, Kudchadker R, Amos R, Johnson J, Zhang Y, Yu Z, Zhang L and Lee A. Evaluation and comparison of inter-fractional femoral head variations for two pelvic immobilization devices. Med Phys 34(6):2384, 6/2007.
80. Kudchadker R, Johnson J, Bruno T and Frank S. Improved homogeneity with fourth generation prostate brachytherapy implants - A revised I-125 seed nomogram. Med Phys 34(6):2459, 6/2007.
81. Nelson C, Balter P, Choi B, Vedam S, Lindsay P, Kudchadker R, Briere T, Chang J, Morice R and Starkschall G. Improvement in the daily alignment of mobile lung tumors using implanted fiducials. Med Phys 34(6):2328, 6/2007.
82. Starkschall G, Beddar S, Johnson J, Kudchadker R, Lawyer A, Tung S and Zhang S. Use of a website for support of a clinical rotation in radiation oncology physics. Med Phys 34(6):2400, 6/2007.
83. Kudchadker RJ, Ha CS, Stokes C, Kirsner SM and Wilder RB. Breast dose reduction in woman undergoing mediastinal radiotherapy using a custom prone immobilization device. Int J Radiat Oncol Biol Phys 66(3):S679, 11/2006.
84. Chueng R, Tucker S, de Crevoisier R, Lee A, Frank S, Kudchadker R, Thames H, Mohan R and Kuban D. Identification of the bladder dose and volume constraints to control late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 66(3):S37-S38, 11/2006.
85. Zhu XR, Zhang L, Kudchadker R, Wu R, Balter P, Mohan R, Gillin M and Dong L. Clinical implementation of cone-beam CT for image-guided radiation therapy. Med Phys 33:2268, 2006.
86. Kudchadker R. Comparison of prostate implanted fiducial with CT and ultrasound for prostate target localization: Initial results. Med Phys 33:2029, 2006.
87. O'Daniel J and Kudchadker R. Dosimetric comparison of the no action level alignment protocol with daily alignment techniques for prostate cancer. Med Phys 33:2253, 2006.
88. Lindsay P, Zhu X, Zhang L, Wu R, Kudchadker R, Salehpour M, Lui R, Mohan R, Gillin M and Dong L. Effect of measured cone-beam CT-density calibration on dose calculations. Med Phys 33:2286, 2006.
89. Kudchadker R, Tolani N, Luo D, Kendall R, Mason B, Steadham R, Kanke J, Rosen I, Gillin M, Prado K. Evaluation and commissioning of K&S Associates Inc. Diamond monitor unit calculation software. Med Phys 33:2098, 2006.
90. Kudchadker R, Zhu X, Zhang L, Lee A, Mohan R, Gillin M and Dong L. Implementation of on-board imager for daily image-guided radiation therapy in a multi vendor environment. Med Phys 33:2038, 2006.
91. Zullo J, Kudchadker R, Wu R, Lee A and Prado K. Implication of CT couch sag on geometrical accuracy during virtual simulation. Med Phys 33:2110, 2006.
92. Liengsawangwong, Kudchadker R, Wu R, Session R, Diel T, Aleman G, Dong L, Gillin M and Zhu X. Mechanical, radiation and imaging isocenter quantification on four Varian on-board imager Clinacs. Med Phys 33:2283, 2006.
93. Melancon A and Kudchadker R. The dosimetric impact of intrafractional motion on IMRT treatment of prostate cancer. Med Phys 33:2187, 2006.
94. Weinberg R, Antolak J, Hogstrom K, Starkschall G, Kudchadker R, Mohan R. Influence of initial pencil beam parameters on large non-applicator electron field profiles calculated using Monte Carlo methods. Med Phys 32:2012, 2005.
95. Weinberg R, Antolak J, Hogstrom K, Starkschall G, Kudchadker R, McNeese M, Tucker S. Mixed-beam therapy and intensity-modulated x-ray therapy: A comparative treatment planning study for head and neck cancer. Med Phys 31:1750-1751, 2004.
96. Weinberg R, Kudchadker R, Antolak J, Morrison W, Hogstrom K. Electron Conformal Therapy as an Alternative to IMXT in the Treatment of Head and Neck Cancer. Med Phys 30:518, 2003.
97. Famiglietti R, Kudchadker R, Chang E, Bryan F, Maor M. Evaluation of radiation exposure from portal films taken during definitive course of pediatric radiotherapy. Int J Radiat Oncol Biol Phys 57(2):S198-S199, 2003.
98. Kirsner S, Kudchadker R, Prado K, Ha C, Wilder R, Cox J. Clinical implementation of incorporating heterogeneity corrections in mantle field irradiation. Radiological Society of North America E10:483, 2002.
99. Kudchadker R, Antolak J, Morrison W, Hogstrom K. Conformal head and neck radiotherapy using custom electron bolus. Med Phys 29:1337, 2002.
100. Prado K, Kirsner S, Kudchadker R, Steadham R, Lane R. Estimation of off-axis asymmetric-field enhanced dynamic wedge factors. Med Phys 29:1202, 2002.
101. Kudchadker R, Antolak J, Hogstrom K. Electron conformal therapy combining bolus and intensity modulation. Med Phys 28, 2001.
102. Kudchadker R, Hogstrom K, Boyd R. Multileaf collimation for electron intensity modulation. Med Phys 27:1375, 2000.

Grant & Contract Support

Title: Designing and implementing an innovative prostate brachytherapy training program using an MRI phantom-based simulator
Funding Source: Radiological Society of North America (RSNA)
Role: Mentor
Principal Investigator: Nikhil Thakar
Duration: 5/15/2014 - present
 
Title: MRI based simulation and treatment planning for localized prostate cancer
Funding Source: ELEKTA
Role: Co-Principal Investigator
Principal Investigator: Thomas J. Pugh
Duration: 7/1/2013 - 6/30/2014
 
Title: Training Grant - MRI enhanced prostate brachytherapy
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT)
Role: Mentor
Duration: 11/1/2012 - 11/1/2013
 
Title: Real-time in vivo rectal wall dosimetry for prostate radiotherapy using plastic scintillating detectors
Funding Source: MDACC - IRG
Role: Principal Investigator
Duration: 2012 - 2014
 
Title: Clinical dosimetry evaluation of accelerator neutron sources for neutron capture therapy
Funding Source: Lockheed Martin Idaho Technologies Company, University Research Consortium
Role: Co-Investigator
Principal Investigator: Frank Harmon
Duration: 1/1/1997 - 1/1/1999

Last updated: 7/28/2014